Chemotherapy (cisplatin)

DRUG2 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Gynecologic CancerHead and Neck Neoplasms

Phase 1

AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy

Gustave Roussy, Cancer Campus, Grand ParisGynecologic Cancer

Start: 2018-05-17End: 2024-05-31Target: 18Updated: 2021-07-07

Phase 3

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

CompletedNCT02918955

Insel Gruppe AG, University Hospital BernHead and Neck Neoplasms

Start: 2016-12-16End: 2025-06-24Updated: 2025-11-20

Related Papers

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

BMC Cancer2023-04-1549 citations